NTA $2.50 +

Where do you get this figure from???

One wonders why the company has not been taken out yet

I have been saying this for ages .... why hasn't any big pharma made moves on Starpharma while our MC is under $200 million ..... perhaps they are just not that interested or the results aren't as good as we have been led to believe ?


AstraZeneca (supposedly Starpharma's biggest and most supportive partner) is throwing billions around in the biotech space at the moment so why not secure the DEP technology at such low prices and take full control ? Truly begs the question why if they are as impressed as some on here would have you believe


Here's 3 recent deals in 2023 where AstraZeneca have pulled the trigger just not with Starpharma ? ...... and still not even a milestone payment for AZD0466 that so many predicted would come more than 12months ago



https://www.ft.com/content/9ee6ff98-81df-4c7e-a779-76de108fc6c2

San Francisco JANUARY 9 2023
AstraZeneca to buy US biotech CinCor in $1.8bn deal




https://www.fiercebiotech.com/biote...ucks-pays-55m-adc-join-peers-hot-cancer-space

May 15, 2023 09:55am
AstraZeneca, spying post-BCMA big bucks, pays $55M for ADC to join peers in hot cancer space



https://www.fiercebiotech.com/biote...t-paying-63m-adc-months-after-bispecific-deal

Feb 23, 2023 04:41am
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal